Screening for lung cancer
127 results
1 - 100Screening for lung cancer
Screening for lung cancer
Screening smokers for lung cancer with low-dose CT decreases lung cancer mortality
Consequences of screening for lung cancer (NELSON)
USPSTF recommends lung cancer screening for some smokers
Uncertain risks and benefits of CT screening for lung cancer
CT screening for lung cancer: more cancers detected, no mortality benefit (DANTE)
Lower mortality with CT screening for lung cancer, but at very high cost
Systematic review: lung cancer screening with CT decreases mortality but with significant harms
Italian lung cancer screening findings consistent with US National Lung Screening Trial results (ITALUNG)
Impact of low‐dose computed tomography (LDCT) screening on lung cancer‐related mortality
Lung cancer screening is cost effective, but only if done correctly
Low-dose CT screening of smokers decreases lung cancer deaths, but not overall mortality
Annual screening chest x-ray does not reduce lung cancer mortality
High false-positive rate with lung cancer screening
Spiral CT detects early lung cancer, but screening use is premature
Lung cancer screening requires additional imaging in 40% of patients in real world
Adherence to lung cancer screening is relatively poor after baseline scan
After community lung cancer screening, rates of follow-up imaging are lower but the rates of some procedures are higher
USPSTF 2021 recommends annual lung cancer screening based on shared decision-making in high-risk adults (B recommendation)
Population screening for cancer
One in five patients overdiagnosed with lung CA screening
Lung cancer is infrequently found via screening, but follow-up imaging is common
Lung cancers
Screening for ovarian cancer with CA-125/ultrasound algorithm does not reduce mortality (UKCTOCS)
Prostate cancer screening: no mortality benefit after 15 years of follow-up (PLCO)
Low-dose CT screening decreases mortality in heavy smokers
Lung cancer screening with low-dose CT does not affect smoking cessation rates
Screening CA-125 and transvaginal ultrasound does not reduce ovarian cancer mortality
Volume-based low-dose CT screening reduces lung cancer–specific mortality (NELSON)
Prostate cancer screening: no mortality benefit after 13 years of follow-up (PLCO)
Lung cancer screening may increase the likelihood of smoking cessation
High false positive rate in repeated, multimodal screening for cancers (PLCO)
CT finds early lung Ca but carries risk (PLuSS)